Skip to Main Content

NEED HEALTH INSURANCE? SHOP OUR PLANS.External Link

NEED HEALTH INSURANCE? SHOP OUR PLANS.External Link

Clinical Payment Policies | Ambetter from Meridian

 

Clinical & Payment Policies

Clinical Policies

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules.  They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies.  Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information. 

All policies found in the Ambetter from Meridian Clinical Policy Manual apply to Ambetter from Meridian members. Policies in the Ambetter from Meridian Clinical Policy Manual may have either a Ambetter from Meridian or a “Centene” heading. Ambetter from Meridian utilizes InterQual® criteria for those medical technologies, procedures or pharmaceutical treatments for which a Ambetter from Meridian clinical policy does not exist.  InterQual is a nationally recognized evidence-based decision support tool.  You may access the InterQual® SmartSheet(s)™ for Adult and Pediatric procedures, durable medical equipment and imaging procedures by logging into the secure provider portal or by calling Ambetter from Meridian. In addition, Ambetter from Meridian may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or  InterQual®criteria is payable by Ambetter from Meridian.   

If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.

For a list of all active clinical policies, see below. For any upcoming policy changes, view the Clinical Policy Updates list

Clinical Policy List
Policy TitlePolicy Number
Acupuncture (PDF)CP.MP.92
Adopted Clinical Practice and Preventive Health GuidelinesCPG Grid
Air Ambulance (PDF)CP.MP.175
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF)CP.MP.108
Applied Behavior Analysis (PDF)CP.BH.104
Articular Cartilage Defect Repairs (PDF)CP.MP.26
Behavioral Health Treatment Documentation Requirements (PDF)HIM.CP.BH.500
Bariatric Surgery (PDF)CP.MP.37
Biofeedback (PDF)CP.MP.168
Biofeedback for Behavioral Health Disorders (PDF)CP.BH.300
Bone-Anchored Hearing Aid (PDF)CP.MP.93
Burn Surgery (PDF)CP.MP.186
Caudal or Interlaminar Epidural Steroid Injections (PDF)CP.MP.164
Clinical Trials (PDF)CP.MP.94
Cochlear Implant Replacements (PDF)CP.MP.14
Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF)V1.2025
Concert Genetic Testing: Cardiac Disorders (PDF)V1.2025
Concert Genetic Testing: Dermatologic Conditions (PDF)V1.2025
Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF)V1.2025
Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)V1.2025
Concert Genetic Testing: Eye Disorders (PDF)V1.2025
Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (PDF)V1.2025
Concert Genetic Testing: General Approach to Genetic and Molecular Testing (PDF)V1.2025
Concert Genetic Testing: Hearing Loss (PDF)V1.2025
Concert Genetic Testing: Hematologic Conditions (non-cancerous) (PDF)V1.2025
Concert Genetic Testing: Hereditary Cancer Susceptibility (PDF)V1.2025
Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)V1.2025
Concert Genetic Testing: Kidney Disorders (PDF)V1.2025
Concert Genetic Testing: Lung Disorders (PDF)V1.2025
Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)V1.2025
Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF)V1.2025
Concert Genetic Testing: Pharmacogenetics (Version A) (PDF)V1.2025
Concert Genetic Testing: Preimplantation Genetic Testing (PDF)V1.2025
Concert Genetic Testing: Prenatal and Preconception Carrier Screening (PDF)V1.2025
Concert Genetic Testing: Prenatal Cell-Free DNA Testing (PDF)V1.2025
Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)V1.2025
Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)V1.2025
Concert Genetics Oncology: Algorithmic Testing (PDF)V1.2025
Concert Genetics Oncology: Cancer Screening (PDF)V1.2025
Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF)V1.2025
Concert Genetics Oncology: Cytogenetic Testing (PDF)V1.2025
Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)V1.2025
Cosmetic and Reconstructive Procedures (PDF)CP.MP.31
Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF)CP.BH.201
Diaphragmatic/Phrenic Nerve Stimulation (PDF)CP.MP.203
Disc Decompression Procedures (PDF)CP.MP.114
Discography (PDF)CP.MP.115
Donor Lymphocyte Infusion (PDF)CP.MP.101
Durable Medical Equipment and Orthotics and Prosthetics Guidelines (PDF)CP.MP.107
Electric Tumor Treating Fields (Optune) (PDF)CP.MP.145
Experimental Technologies (PDF)CP.MP.36
Facet Joint Interventions (PDF)CP.MP.171
Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF)CP.MP.248
Fecal Incontinence Treatments (PDF)CP.MP.137
Fertility Preservation (PDF)CP.MP.130
Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF)CP.MP.129
Functional MRI (PDF)CP.MP.43
Gastric Electrical Stimulation (PDF)CP.MP.40
Gender-Affirming Procedures (PDF)CP.MP.95
Heart-Lung Transplant (PDF)CP.MP.132
Home Births (PDF)CP.MP.136
Home Ventilators (PDF)CP.MP.184
Hospice Services (PDF)CP.MP.54
Hyperhidrosis Treatments (PDF)CP.MP.62
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF)CP.MP.180
Implantable Intrathecal or Epidural Pain Pump (PDF)CP.MP.173
Implantable Loop Recorder (PDF)CP.MP.243
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF)CP.MP.160
Intensity-Modulated Radiotherapy (PDF)CP.MP.69
Intestinal and Multivisceral Transplant (PDF)CP.MP.58
Intradiscal Steroid Injections for Pain Management (PDF)CP.MP.167
IV Moderate Sedation, IV Deep Sedation and General Anesthesia for Dental Procedures (PDF)CP.MP.61
Lantidra (donislecel): Allogeneic Pancreatic Islet Cellular Therapy (PDF)CP.MP.250
Liposuction for Lipedema (PDF)CP.MP.244
Long Term Care Placement (PDF)CP.MP.71
Lung Transplantation (PDF)CP.MP.57
Lysis of Epidural Lesions (PDF)CP.MP.116
Mechanical Stretching Devices for Joint Stiffness (PDF)CP.MP.144
Multiple Sleep Latency Testing (PDF)CP.MP.24
Neonatal Abstinence Syndrome Guidelines (PDF)CP.MP.86
Neonatal Sepsis Management (PDF)CP.MP.85
Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF)CP.MP.48
Nerve Blocks and Neurolysis for Pain Management (PDF)CP.MP.170
NICU Apnea Bradycardia Guidelines (PDF)CP.MP.82
NICU Discharge Guidelines (PDF)CP.MP.81
Nonmyeloablative Allogeneic Stem Cell Transplants (PDF)CP.MP.141
Obstetrical Home Care Programs (PDF)CP.MP.91
Omisirge (omidubicel): Nicotinamide-Modified Allogeneic Hematopoietic Progenitor Cell Therapy (PDF)CP.MP.249
Orthognathic Surgery (PDF)CP.MP.202
Osteogenic Stimulation (PDF)CP.MP.194
Outpatient Cardiac Rehabilitation (PDF)CP.MP.176
Outpatient Oxygen Use (PDF)CP.MP.190
Pancreas Transplantation (PDF)CP.MP.102
Panniculectomy (PDF)CP.MP.109
Pediatric Heart Transplant (PDF)CP.MP.138
Pediatric Kidney Transplant (PDF)CP.MP.246
Pediatric Liver Transplant (PDF)CP.MP.120
Pediatric Oral Function Therapy (PDF)CP.MP.188
Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF)CP.MP.147
Phototherapy for Neonatal Hyperbilirubinemia (PDF)CP.MP.150
Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF)CP.MP.133
Proton and Neutron Beam Therapies (PDF)CP.MP.70
Physical, Occupational, and Speech Therapy Services (PDF)CP.MP.49
Reduction Mammoplasty and Gynecomastia Surgery (PDF)CP.MP.51
Repair of Nasal Valve Compromise (PDF)CP.MP.210
Sacroiliac Joint Fusion (PDF)CP.MP.126
Sacroiliac Joint Interventions for Pain Management (PDF)CP.MP.166
Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF)CP.MP.146
Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF)CP.MP.174
Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF)CP.MP.165
Short Inpatient Hospital Stay (PDF)CP.MP.182
Skin and Soft Tissue Substitutes for Chronic Wounds (PDF)CP.MP.185
Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF)CP.MP.117
Stereotactic Body Radiation Therapy (PDF)CP.MP.22
Tandem Transplant (PDF)CP.MP.162
Therapeutic Utilization of Inhaled Nitric Oxide (PDF)CP.MP.87
Total Artificial Heart (PDF)CP.MP.127
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF)CP.MP.163
Transcranial Magnetic Stimulation for Treatment Resistant Major Depressi (PDF)CP.BH.200
Transplant Service Documentation Requirements (PDF)CP.MP.247
Trigger Point Injections for Pain Management (PDF)CP.MP.169
Urinary Incontinence Devices and Treatments (PDF)CP.MP.142
Vagus Nerve Stimulation (PDF)CP.MP.12
Ventricular Assist Devices (PDF)CP.MP.46

Payment Policies

Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether health care services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for  physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.

All policies found in the Ambetter from Meridian Payment Policy Manual apply with respect to Ambetter from Meridian members. Policies in the Ambetter from Meridian Payment Policy Manual may have either a Ambetter from Meridian or a “Centene” heading.  In addition, Ambetter from Meridian may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Ambetter from Meridian.

If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.

POLICY TITLEEFFECTIVE DATE
25-hydroxyvitamin D Testing in Children and Adolescents (CP.MP.157) (PDF)Effective Date: 12/12/2024
3-Day Payment Window (PDF)Effective Date: 7/01/2014
30 Day Readmission (PDF)Effective Date: 1/01/2015
Allergy Testing and Therapy (CP.MP.100) (PDF)Effective Date: 12/12/2024
Bronchial Thermoplasty (CP.MP.110) (PDF)Effective Date: 12/12/2024
Concert Laboratory Payment Policy (PDF)Effective Date: 6/1/2024
Digital EEG Spike Analysis (CP.MP.105) (PDF)Effective Date: 12/12/2024
E&M Services Billed with Treatment Room (PDF)Effective Date: 4/7/2021
EEG in the Evaluation of Headache (CP.MP.155) (PDF)Effective Date: 12/12/2024
Endometrial Ablation (CP.MP.106) (PDF)Effective Date: 12/12/2024
Evoked Potential Testing (CP.MP.134) (PDF)Effective Date: 12/12/2024
Genetic and Molecular Testing Services (PDF)Effective Date: 6/1/2024
Helicobacter Pylori Serology Testing (CP.MP.153) (PDF)Effective Date: 12/12/2024
Holter Monitors (PDF)Effective Date: 7/10/2024
Infectious Disease: Dermatologic Lab Testing (PDF)Effective Date: 6/1/2024
Infectious Disease: Gastroenterologic Lab Testing (PDF)Effective Date: 6/1/2024
Infectious Disease: Genitourinary Lab Testing (PDF)Effective Date: 6/1/2024
Infectious Disease: Primary Care & Preventive Lab Screening (PDF)Effective Date: 6/1/2024
Infectious Disease: Multisystem Lab Testing (PDF)Effective Date: 6/1/2024
Infectious Disease: Respiratory Lab Testing (PDF)Effective Date: 6/1/2024
Infectious Disease: Vector-borne and Tropical Diseases Lab Testing (PDF)Effective Date: 6/1/2024
Laser Therapy for Skin Conditions (PDF)Effective Date: 7/20/2024
Measurement of Serum 1,25-dihydroxyvitamin D (PDF)Effective Date: 7/22/2024
Multiple Diagnostic Cardiovascular Procedure Payment Reduction (MDCR) (PDF)Effective Date: 2/1/2023
Multiple Procedure Payment Reduction for Therapeutic Services (PDF)Last Review Date: 8/23/2020
Non-obstetrical and Obstetrical Transabdominal and Transvaginal Ultrasounds  (PDF)Effective Date: 4/1/2022
Physician’s Office Lab Testing (PDF)Effective Date: 8/1/2021
 Pulmonary Function Testing (CP.MP.242) (PDF)Effective Date: 12/12/2024
Renal Hemodialysis (PDF)Effective Date: 4/1/2022
Robotic Surgery (PDF)Effective Date: 3/1/2023
Skilled Nursing Facility Leveling (CC.PP.206) (PDF)Effective Date: 11/21/2024
Sleep Studies Place of Service (PDF)Effective Date: 4/1/2022
Thyroid Hormones and Insulin Testing in Pediatrics (CP.MP.154) (PDF)Effective Date: 12/12/2024
Ultrasound in Pregnancy (CP.MP.38) (PDF)Effective Date: 12/12/2024
Urine Specimen Validity Testing (PDF)Effective Date: 4/1/2022
Urodynamic Testing (CP.MP.98) (PDF)Effective Date: 12/12/2024
Wheelchairs and Accessories (PDF)Effective Date: 9/1/2022
Wheelchair Seating (CP.MP.99) (PDF)Effective Date: 12/12/2024
Wireless Motility Capsule (CP.MP.143) (PDF)Effective Date: 12/12/2024

Pharmacy Policies

Policy NumberPolicy Title
CP.PHAR.345Abaloparatide (Tymlos) (PDF) Effective Date: 3/1/2025
CP.PHAR.355Abemaciclib (Verzenio) (PDF)Ciprofloxacin/Fluocinolone (Otovel) (PDF)
CP.PHAR.84Abiraterone (Zytiga, Yonsa) (PDF) Effective Date: 5/1/2025
CP.PHAR.578Abrocitinib (Cibinqo) (PDF)
CP.PHAR.230AbobotulinumtoxinA (Dysport) (PDF)
CP.PHAR.366Acalabrutinib (Calquence) (PDF) Effective Date: 5/1/2025
CP.PMN.210Acyclovir Buccal Tablet (Sitavig) (PDF)
CP.PHAR.605Adagrasib (Krazati) (PDF) Effective Date: 3/1/2025
CP.PHAR.142Adefovir (Hepsera) (PDF)
CP.PHAR.635ADAMTS13, Recombinant-krhn (Adzynma) (PDF) Effective Date: 3/1/2025
CP.PHAR.229Ado-Trastuzumab Emtansine (Kadcyla) (PDF)
CP.PHAR.468Aducanumab-avwa (Aduhelm) (PDF)
CP.PHAR.444Afamelanotide (Scenesse) (PDF) Effective Date: 5/1/2025
CP.PHAR.678Afamitresgene Autoleucel (Tecelra) (PDF)
CP.PHAR.298Afatinib (Gilotrif) (PDF)
CP.PHAR.184Aflibercept (Eylea, Eylea HD), Aflibercept-yszy (Opuviz), Aflibercept-jbvf (Yesafili), Aflibercept-mrbb (Ahzantive), Aflibercept-abzv (Enzeevu), Aflibercept-ayyh (Pavblu) (PDF) Effective Date: 5/1/2025
CP.PHAR.158Agalsidase Beta (Fabrazyme) (PDF)
CP.PMN.138Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF)
CP.PHAR.369Alectinib (Alecensa) (PDF)
CP.PHAR.243Alemtuzumab (Lemtrada) (PDF)
CP.PMN.88Alendronate (Binosto, Fosamax Plus D) (PDF) Effective Date: 5/1/2025
CP.PHAR.160Alglucosidase Alfa (Lumizyme) (PDF) Effective 5/1/2025
CP.PHAR.562Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF) Effective Date: 3/1/2025
CP.PHAR.563Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF) Effective Date: 5/1/2025
CP.PHAR.94Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF)External Link Effective Date: 3/1/2025
CP.PHAR.430Alpelisib (Piqray, Vijoice) (PDF)
CP.PMN.89Amantadine ER (Gocovri, Osmolex ER) (PDF) Effective Date: 3/1/2025
CP.PHAR.190Ambrisentan (Letairis) (PDF) Effective Date: 5/1/2025
CP.PHAR.411Amifampridine (Firdapse) (PDF) Effective Date: 3/1/2025
CP.PHAR.401Amikacin (Arikayce) (PDF)
CP.PMN.236Amisulpride (Barhemsys) (PDF)
CP.PHAR.544Amivantamab-vmjw (Rybrevant) (PDF)
CP.PHAR.551Anifrolumab-fnia (Saphnelo) (PDF)
CP.PHAR.217Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF) Effective Date: 3/1/2025
CP.PHAR.564Antithrombin III (ATryn, Thrombate III)  (PDF) Effective Date: 3/1/2025
CP.PHAR.506Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF)
CP.PCH.45Apalutamide (Erleada) (PDF)
CP.PHAR.488Apomorphine (Apokyn, Kynmobi) (PDF)
CP.PMN.19Aprepitant (Aponvie, Emend, Cinvanti), Fosaprepitant (Emend for injection, Focinvez) (PDF)
CP.PHAR.676Aprocitentan (Tryvio) (PDF)
CP.PHAR.510Arimoclomol (Miplyffa) (PDF) Effective Date: 3/1/2025
CP.PHAR.290Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (PDF)
CP.PCH.37Aripiprazole Orally Disintegrating Tablet (PDF) Effective Date: 3/1/2025
CP.PMN.300Aripiprazole Orally Disintegrating Tablet, Oral Film (Opipza) (PDF) Effective Date: 3/1/2025
CP.PCH.37Aripiprazole ODT (Abilify) (PDF)
CP.PMN.35Armodafinil (Nuvigil) (PDF)
CP.PHAR.565Asciminib (Scemblix) (PDF) Effective Date: 5/1/2025
CP.PMN.15Asenapine (Saphris, Secuado) (PDF)
CP.PHAR.328Asfotase Alfa (Strensiq) (PDF)
CP.PHAR.328Asfotase Alfa (Strensiq) (PDF)
CP.PMN.20Aspirin/Dipyridamole (Aggrenox) (PDF) Effective Date: 3/1/2025
CP.PHAR.235Atezolizumab (Tecentriq), Atezolizumab-Hyaluronidase (Tecentriq Hybreza) (PDF) Effective Date: 5/1/2025
CP.PHAR.602Atidarsagene autotemcel (Lenmeldy) (PDF) Effective Date: 3/1/2025
CP.PHAR.566Atogepant (Qulipta) (PDF)External Link
CP.PHAR.641Avacincaptad pegol (Izervay) (PDF)
CP.PHAR.521Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF)
CP.PHAR.515Avacopan (Tavneos) (PDF) Effective Date: 5/1/2025
CP.PHAR.521Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF) Effective Date: 5/1/2025
CP.PHAR.454Avapritinib (Ayvakit) (PDF) Effective Date: 5/1/2025
CP.PHAR.130Avatrombopag (Doptelet) (PDF)
CP.PHAR.333Avelumab (Bavencio) (PDF) Effective Date: 5/1/2025
CP.PHAR.691Axatilimab-csfr (Niktimvo) (PDF)
CP.PHAR.362Axicabtagene Ciloleucel (Yescarta) (PDF) Effective Date: 3/1/2025
CP.PHAR.100Axitinib (Inlyta) (PDF) Effective Date: 5/1/2025
CP.PHAR.387Azacitidine (Onureg, Vidaza) (PDF)
HIM.PA.119Azelaic Acid (Finacea Topical Gel/Foam) (PDF)
CP.PHAR.209Aztreonam (Cayston) (PDF)
CP.PHAR.149Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF)
CP.PMN.185Baloxavir Marboxil (Xofluza) (PDF)
CP.PMN.212Bedaquiline (Sirturo) (PDF) Effective Date: 3/1/2025
CP.PHAR.469Belantamab Mafodotin-blmf (Blenrep) (PDF)
CP.PHAR.201Belatacept (Nulojix) (PDF)
CP.PHAR.88Belimumab (Benlysta) (PDF)
CP.PHAR.311 Belinostat (Beleodaq) (PDF)
CP.PHAR.552Belumosudil (Rezurock) (PDF)
CP.PHAR.553Belzutifan (Welireg) (PDF)
CP.PMN.237Bempedoic Acid (Nexletol), Bempedoic Acid/Ezetimibe (Nexlizet) (PDF) Effective Date: 5/1/2025
CP.PHAR.307Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF)
HIM.PA.SP70Benralizumab (Fasenra) (PDF) Effective Date: 3/1/2025
CP.PMN.90Benznidazole (PDF) Effective Date: 3/1/2025
CP.PMN.293Berdazimer (Zelsuvmi) (PDF)
CP.PHAR.592Beremagene geperpavec-svdt (Vyjuvek) (PDF)
HIM.PA.169Berotralstat (Orladeyo) (PDF)
CP.PHAR.143Betaine (Cystadane) (PDF)
CP.PMN.182Betamethasone Dipropionate Spray (Sernivo) (PDF)
CP.PHAR.545Betibeglogene Autotemcel (Zynteglo) (PDF)
CP.PHAR.93Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF)
CP.PHAR.75Bexarotene (Targretin Capsules, Gel) (PDF)
CP.PHAR.300Bezlotoxumab (Zinplava) (PDF) Effective Date: 3/1/2025
CP.PHAR.486Bimatoprost Implant (Durysta) (PDF)
CP.PHAR.50Binimetinib (Mektovi) (PDF)
HIM.PA.SP60Biologic and Non-biologic DMARDs (PDF) Effective Date: 5/1/2025
CP.PHAR.669Birch Triterpenes (Filsuvez) (PDF) Effective Date: 5/1/2025
CP.PHAR.312Blinatumomab (Blincyto) (PDF)
CP.PHAR.410Bortezomib (Velcade) (PDF) Effective Date: 5/1/2025
CP.PHAR.191Bosutinib (Bosulif) (PDF) Effective Date: 5/1/2025
CP.PHAR.105Bosutinib (Bosulif) (PDF)
HIM.PA.103Brand Name Override and Non-Formulary Medications (PDF)
CP.PHAR.303Brentuximab Vedotin (Adcetris) (PDF)
CP.PHAR.417Brexanolone (Zulresso) (PDF)
CP.PMN.68Brexpiprazole (Rexulti) (PDF)
CP.PHAR.472Brexucabtagene Autoleucel (Tecartus) (PDF) Effective Date: 3/1/2025
CP.PHAR.342Brigatinib (Alunbrig) (PDF)
CP.PMN.192Brimonidine Tartrate (Mirvaso)
HIM.PA.15Brinzolamide/Brimonidine (Simbrinza) (PDF)
CP.PMN.297 Brivaracetam (Briviact) (PDF)
CP.PHAR.445Brolucizumab-dbll (Beovu) (PDF) Effective Date: 5/1/2025
CP.PMN.294Budesonide (Eohilia, Uceris) (PDF)
CP.PHAR.572Budesonide (Tarpeyo) (PDF) Effective Date: 3/1/2025
CP.PMN.82Buprenorphine (Subutex) (PDF) Effective Date: 3/1/2025
CP.PHAR.289Buprenorphine Injection (Sublocade, Brixadi) (PDF) Effective Date: 5/1/2025
CP.PMN.81Buprenorphine/Naloxone (Suboxone, Zubsolv) (PDF) Effective Date: 3/1/2025
CP.PCH.12Bupropion/Naltrexone (Contrave) (PDF)
CP.PHAR.11Burosumab-twza (Crysvita) (PDF)
HIM.PA.46Butorphanol Nasal Spray (PDF)
HIM.PA.170C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF)
CP.PHAR.316Cabazitaxel (Jevtana) (PDF)
CP.PHAR.573Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF) Effective Date: 3/1/2025
CP.PHAR.111Cabozantinib (Cabometyx, Cometriq) (PDF) Effective Date: 5/1/2025
CP.PMN.76Calcifediol (Rayaldee) (PDF)
CP.PMN.181Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF)
CP.PHAR.246Canakinumab (Ilaris) (PDF)
CP.PMN.164Cannabidiol (Epidiolex) (PDF)
CP.PHAR.60Capecitabine (Xeloda) (PDF)
CP.PHAR.663Capivasertib (Truqap) (PDF) Effective Date: 3/1/2025
CP.PHAR.416Caplacizumab-yhdp (Cablivi) (PDF)
CP.PHAR.494Capmatinib (Tabrecta) (PDF)
CP.PMN.238Carbidopa/Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa), IR Tablets (Dhivy) (PDF)
CP.PHAR.309Carfilzomib (Kyprolis) (PDF)
CP.PHAR.206Carglumic Acid (Carbaglu) (PDF) Effective Date: 5/1/2025
CP.PMN.91Cariprazine (Vraylar) (PDF)
CP.PHAR.470Casimersen (Amondys 45) (PDF) Effective Date: 3/1/2025
CP.PHAR.397Cemiplimab-rwlc (Libtayo) (PDF)
CP.PMN.186Cenegermin-bkbj (Oxervate) (PDF) Effective Date: 3/1/2025
CP.PMN.231Cenobamate (Xcopri) (PDF) Effective Date: 3/1/2025
CP.PHAR.422Cladribine (Mavenclad) (PDF)
CP.PHAR.349Ceritinib (Zykadia) (PDF)
CP.PHAR.338Cerliponase Alfa (Brineura) (PDF)
CP.PHAR.317Cetuximab (Erbitux) (PDF)
CP.PMN.239Chenodiol (Chenodal) (PDF)
CP.PHAR.554Chlorambucil (Leukeran) (PDF)
CP.PHAR.388Chloramphenicol Sodium Succinate (PDF)
CP.PHAR.390Cholic Acid (Cholbam) (PDF)
CP.PMN.24Ciclopirox Topical Solution 8% (PDF) Effective Date: 3/1/2025
CP.PHAR.533Ciltacabtagene Autoleucel (Carvykti) (PDF)
CP.PHAR.61Cinacalcet (Sensipar) (PDF)
CP.PHAR.567Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF) Effective Date: 5/1/2025
CP.PMN.248Ciprofloxacin/Dexamethasone (Ciprodex) (PDF)
CP.PMN.249Ciprofloxacin/Fluocinolone (Otovel) (PDF)
CP.PMN.257Clascoterone (Winlevi) (PDF) Effective Date: 3/1/2025
CP.PMN.54Clobazam (Onfi, Sympazan) (PDF)
CP.PMN.92CNS Stimulants (PDF) Effective Date: 5/1/2025
CP.PHAR.380Cobimetinib (Cotellic) (PDF)Copanlisib (Aliqopa) (PDF)
CP.PMN.123Colchicine (Colcrys, Lodoco) (PDF) Effective Date: 5/1/2025
CP.PMN.250Colesevelam (Welchol) (PDF)
CP.PHAR.82Collagenase Clostridium Histolyticum (Xiaflex) (PDF)External Link
CP.PCH.43Colonoscopy Preparation Products (PDF)
CP.PMN.280Compounded Medications (PDF)
CP.PMN.258Conjugated Estrogens/Bazedoxifene (Duavee) (PDF) Effective Date: 3/1/2025
CP.PMN.214Continuous Glucose Monitors (PDF) Effective Date: 3/1/2025
CP.PHAR.357Copanlisib (Aliqopa) (PDF)
CP.PHAR.385Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF)
CP.PHAR.711Cosibelimab-Ipdl (Unloxcyt) (PDF) Effective Date: 3/1/2025
CP.PHAR.203Cosyntropin (Cortrosyn) (PDF) Effective Date: 5/1/2025
CP.PMN.110Crisaborole (Eucrisa) (PDF)
CP.PHAR.449Crizanlizumab-tmca (Adakveo) (PDF) Effective Date: 3/1/2025
CP.PHAR.90Crizotinib (Xalkori) (PDF)
CP.PHAR.664Crovalimab-akkz (PiaSky) (PDF) Effective Date: 3/1/2025
CP.PMN.48Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF)
CP.PMN.130Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF)
CP.PHAR.155Cysteamine oral (Cystagon, Procysbi) (PDF)
CP.PHAR.277Cytomegalovirus Immune Globulin (CytoGam) (PDF)
CP.PHAR.239Dabrafenib (Tafinlar) (PDF)
CP.PHAR.399Dacomitinib (Vizimpro) (PDF)
CP.PHAR.248Dalfampridine (Ampyra) (PDF)
CP.PHAR.225Dalteparin (Fragmin) (PDF) Effective Date: 5/1/2025
CP.PHAR.665Danicopan (Voydeya) (PDF)
CP.PHAR.628Daprodustat (Jesduvroq) (PDF)
CP.PCH.32Dapsone (Aczone Gel) (PDF)
CP.PHAR.351Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (PDF)
CP.PHAR.310Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF)
CP.PHAR.236Darbepoetin Alfa (Aranesp) (PDF)
CP.PHAR.435Darolutamide (Nubeqa) (PDF)
HIM.PA.SP61Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir (Viekira Pak) (PDF)
CP.PHAR.72Dasatinib (Sprycel, Phyrago) (PDF)
CP.PHAR.352Daunorubicin/Cytarabine (Vyxeos) (PDF)
CP.PHAR.651DaxibotulinumtoxinA-lanm (Daxxify) (PDF)
CP.PHAR.479Decitabine/Cedazuridine (Inqovi) (PDF)
CP.PHAR.145Deferasirox (Exjade, Jadenu) (PDF)
CP.PHAR.147Deferiprone (Ferriprox) (PDF)
CP.PHAR.146Deferoxamine (Desferal) (PDF)
CP.PHAR.331Deflazacort (Emflaza) (PDF) Effective Date: 3/1/2025
CP.PHAR.170Degarelix Acetate (Firmagon) (PDF)
CP.PMN.115Delafloxacin (Baxdela) (PDF)
CP.PHAR.593Delandistrogene Moxeparvovec-rokl (Elevidys) (PDF)
CP.PHAR.693Denileukin Diftitox-cxdl (Lymphir) (PDF)
CP.PHAR.58Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF) Effective Date: 5/1/2025
CP.PHAR.214Desmopressin Acetate (DDAVP, Stimate, Nocdurna) (PDF) Effective Date: 5/1/2025
CP.PCH.42Deutetrabenazine (Austedo, Austedo XR) (PDF)
CP.PHAR.418Dexrazoxane (Totect) (PDF)
CP.PMN.284Dextromethorphan/Bupropion (Auvelity) (PDF)
CP.PMN.284Dextromethorphan-bupropion (Auvelity) (PDF)
CP.PMN.93Dextromethorphan-Quinidine (Nuedexta) (PDF) Effective Date: 3/1/2025
CP.PMN.216Diazepam Nasal Spray (Valtoco) (PDF)
CP.PMN.261Dichlorphenamide (Keveyis) (PDF) Effective Date: 3/1/2025
CP.PCH.28Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF)
CP.PHAR.249Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF)
HIM.PA.58Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (PDF) Effective Date: 3/1/2025
CP.PMN.141Dolasetron (Anzemet) (PDF)
CP.PHAR.594Donanemab-azbt (Kinsunla) (PDF)
CP.PHAR.212Dornase Alfa (Pulmozyme) (PDF)
CP.PHAR.540Dostarlimab-gxly (Jemperli) (PDF)
CP.PMN.175Doxepin (Silenor) (PDF)
HIM.PA.147Doxepin (Silenor, Prudoxin, Zonalon) (PDF)
CP.PMN.79Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF)
HIM.PA.SP69Dupilumab (Dupixent) (PDF) Effective Date: 5/1/2025
CP.PMN.128Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF)
CP.PHAR.400Duvelisib (Copiktra) (PDF)
CP.PHAR.177Ecallantide (Kalbitor) (PDF)
CP.PHAR.97Eculizumab (Soliris) (PDF)
CP.PHAR.343Edaravone (Radicava, Radicava ORS) (PDF)
CP.PHAR.555Efgartigimod alfa, efgartigimod-hyaluronidase (Vyvgart, Vyvgart Hytrulo) (PDF)Elacestrant (Orserdu) Effective Date: 5/1/2025
CP.PMN.25Efgartigimod Alfa-fcab, Efgartigimod/Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF) Effective Date: 3/1/2025
CP.PHAR.670Eflornithine (Iwilfin) (PDF) Effective Date: 3/1/2025
CP.PHAR.623Elacestrant (Orserdu) (PDF)
CP.PHAR.595Eladocagene Exuparvovec-tneq (Kebilidi) (PDF) Effective Date: 3/1/2025
CP.PHAR.688Elafibranor (Iqirvo) (PDF)
CP.PHAR.136Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn) (PDF)Elapegademase-lvlr (Revcovi)
CP.PHAR.419Elapegademase-lvlr (Revcovi) (PDF)
HIM.PA.SP62Elbasvir/Grazoprevir (Zepatier) (PDF)
CP.PHAR.440Elexacaftor/Ivacaftor/Tezacaftor; Ivacaftor (Trikafta) (PDF) Effective Date: 3/1/2025
CP.PHAR.153Eliglustat (Cerdelga) (PDF)
CP.PHAR.556Elivaldogene Autotemcel (Skysona) (PDF)
CP.PHAR.162Elosulfase Alfa (Vimizim) (PDF)
CP.PHAR.308Elotuzumab (Empliciti) (PDF)
CP.PHAR.652Elranatamab-bcmm (Elrexfio) (PDF)
CP.PHAR.180Eltrombopag (Alvaiz, Promacta) (PDF) Effective Date: 5/1/2025
CP.PMN.170Eluxadoline (Viberzi) (PDF)
CP.PHAR.402Emapalumab-lzsg (Gamifant) (PDF) Effective Date: 3/1/2025
CP.PHAR.370Emicizumab-kxwh (Hemlibra) (PDF) Effective Date: 3/1/2025
CP.PMN.235Emtricitabine/Tenofovir Alafenamide (Descovy) (PDF) Effective Date: 3/1/2025
CP.PHAR.363Enasidenib (Idhifa) (PDF)
CP.PHAR.127Encorafenib (Braftovi) (PDF)
CP.PHAR.455Enfortumab Vedotin-ejfv (Padcev) (PDF) Effective Date: 3/1/2025
CP.PHAR.41Enfuvirtide (Fuzeon) (PDF)
CP.PHAR.224Enoxaparin (Lovenox) (PDF) Effective Date: 3/1/2025
CP.PHAR.712Ensartinib (Ensacove) (PDF) Effective Date: 3/1/2025
HIM.PA.08Entecavir (Baraclude) (PDF)
CP.PHAR.441Entrectinib (Rozlytrek) (PDF)
CP.PHAR.106Enzalutamide (Xtandi) (PDF) Effective Date: 3/1/2025
CP.PHAR.634Epcoritamab-bysp (Epkinly) (PDF)
CP.PHAR.633Eplontersen (Wainua) (PDF)
CP.PHAR.237Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF)
CP.PHAR.192Epoprostenol (Flolan, Veletri) (PDF) Effective Date: 3/1/2025
HIM.PA.SP64Eptinezumab-jjmr (Vyepti) (PDF)
CP.PHAR.423Erdafitinib (Balversa) (PDF)
HIM.PA.SP65Erenumab-aooe (Aimovig) (PDF)
CP.PHAR.318Eribulin Mesylate (Halaven) (PDF)
CP.PHAR.74Erlotinib (Tarceva) (PDF)
CP.PHAR.301Erwinia Asparaginase (Rylaze) (PDF)
CP.PMN.199Esketamine (Spravato) (PDF)
CP.PMN.263Estradiol Vaginal Ring (Femring) (PDF)
CP.PHAR.379Etelcalcetide (Parsabiv) (PDF)
CP.PHAR.288Eteplirsen (Exondys 51) (PDF) Effective Date: 3/1/2025
CP.PHAR.580Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF) Effective Date: 3/1/2025
CP.PHAR.603Exagamglogene Autotemcel (Casgevy) (PDF)
CP.PHAR.63Everolimus (Afinitor, Afinitor Disperz, Zortress) (PDF) Effective Date: 5/1/2025
HIM.PA.166Evinacumab-dgnb (Evkeeza) (PDF) Effective Date: 5/1/2025
HIM.PA.156Evolocumab (Repatha) (PDF) Effective Date: 5/1/2025
CP.PHAR.603Exagamglogene Autotemcel (Casgevy) (PDF) Effective Date: 3/1/2025
CP.PHAR.218Factor IX (Human, Recombinant) (PDF) Effective Date: 3/1/2025
CP.PHAR.219Factor IX Complex, Human (Profilnine) (PDF) Effective Date: 3/1/2025
CP.PHAR.220Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF) Effective Date: 3/1/2025
CP.PHAR.215Factor VIII (Human, Recombinant) (PDF) Effective Date: 3/1/2025
CP.PHAR.216Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF) Effective Date: 5/1/2025
CP.PHAR.222Factor XIII A-Subunit, Recombinant (Tretten) (PDF) Effective Date: 3/1/2025
CP.PHAR.221Factor XIII, Human (Corifact) (PDF) Effective Date: 3/1/2025
CP.PHAR.456Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF) Effective Date: 5/1/2025
CP.PHAR.581Faricimab-svoa (Vabysmo) (PDF) Effective Date: 5/1/2025
CP.PMN.57Febuxostat (Uloric) (PDF) Effective Date: 5/1/2025
CP.PHAR.613Fecal Microbiota, Live-jslm (Rebyota) (PDF) Effective Date: 3/1/2025
CP.PHAR.632Fecal Microbiota Spores, Live-brpk (Vowst) (PDF)
CP.PHAR.442Fedratinib (Inrebic) (PDF)
CP.PMN.246Fenfluramine (Fintepla) (PDF)
CP.PMN.127Fentanyl IR (Actiq, Fentora, Lazanda, Subsys) (PDF)
CP.PHAR.234Ferric Carboxymaltose (Injectafer) (PDF) Effective Date: 3/1/2025
CP.PHAR.480Ferric Derisomaltose (Monoferric) (PDF)
CP.PMN.213Ferric Maltol (Accrufer) (PDF)
CP.PHAR.624Ferric Pyrophosphate (Triferic, Triferic Avnu) (PDF)
CP.PHAR.165Ferumoxytol (Feraheme) (PDF) Effective Date: 5/1/2025
CP.PMN.289Fezolinetant (Veozah) (PDF)
CP.PHAR.526Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF)
CP.PHAR.643Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF)
CP.PHAR.297Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko) (PDF)
CP.PMN.266Finerenone (Kerendia) (PDF)
CP.PCH.38Fingolimod (Gilenya, Tascenso ODT) (PDF)
CP.PHAR.446Flibanserin (Addyi) (PDF)
CP.PMN.165Fluorouracil Cream (Tolak) (PDF)
CP.PMN.95Fluticasone propionate (Xhance) (PDF)
CP.PHAR.226Fondaparinux (Arixtra) (PDF) Effective Date: 3/1/2025
CP.PHAR.471Fosdenopterin (Nulibry) (PDF)
CP.PHAR.24Fostamatinib (Tavalisse) (PDF) Effective Date: 3/1/2025
CP.PHAR.516Fostemsavir (Rukobia) (PDF) Effective Date: 3/1/2025
HIM.PA.SP66Fremanezumab-vfrm (Ajovy) (PDF)
CP.PHAR.666Fruquintinib (Fruzaqla) (PDF) Effective Date: 3/1/2025
CP.PHAR.424Fulvestrant (Faslodex Injection) (PDF)
CP.PHAR.608Furosemide (Furoscix) (PDF) Effective Date: 3/1/2025
CP.PHAR.604Futibatinib (Lytgobi) (PDF) Effective Date: 5/1/2025
CP.PMN.240Gabapentin ER (Gralise, Horizant) (PDF)External Link
HIM.PA.SP67Galcanezumab-gnlm (Emgality) (PDF)
CP.PHAR.161Galsulfase (Naglazyme) (PDF)
CP.PMN.278Ganaxolone (Ztalmy) (PDF)
CP.PHAR.68Gefitinib (Iressa) (PDF)
CP.PHAR.358Gemtuzumab Ozogamicin (Mylotarg) (PDF)
CP.PMN.292Gepirone (Exxua) (PDF)
CP.PHAR.412Gilteritinib (Xospata) (PDF) Effective Date: 3/1/2025
CP.PHAR.644Givinostat (Duvyzat) (PDF)
CP.PHAR.457Givosiran (Givlaari) (PDF) Effective Date: 3/1/2025
CP.PHAR.413Glasdegib (Daurismo) (PDF) Effective Date: 3/1/2025
CP.PHAR.252Glatiramer Acetate (Copaxone, Glatopa) (PDF)
CP.PMN.286Glaucoma Agents (PDF) Effective Date: 5/1/2025
HIM.PA.SP36Glecaprevir/Pibrentasvir (Mavyret) (PDF)
CP.PHAR.636Glofitamab-gxbm (Columvi) (PDF)
HIM.PA.53GLP-1 receptor agonists (PDF) Effective Date: 3/1/2025
CP.PHAR.207Glycerol Phenylbutyrate (Ravicti) (PDF) Effective Date: 3/1/2025
CP.PHAR.453Golodirsen (Vyondys 53) (PDF) Effective Date: 3/1/2025
CP.PHAR.171Goserelin Acetate (Zoladex) (PDF)
CP.PMN.74Granisetron (Sancuso, Sustol) (PDF)
HIM.PA.20Halcinonide (Halog) (PDF)
CP.PMN.180Halobetasol Propionate (Bryhali, Lexette, Ultravate) (PDF)
CP.PMN.208Halobetasol Propionate/Tazarotene (Duobrii) (PDF)
CP.PHAR.181Hemin (Panhematin) (PDF)External Link Effective Date: 3/1/2025
CP.PHAR.172Histrelin Acetate (Vantas, Supprelin LA) (PDF)
CP.PMN.111House Dust Mite Allergen Extract (Odactra) (PDF)
HIM.PA.161Human Growth Hormone (Somapacitan, Somatrogon, Somatropin, Lonapegsomatropin-tcgd) (PDF) Effective Date: 3/1/2025
CP.PHAR.05Hyaluronate Derivatives (PDF)
CP.PHAR.14Hydroxyprogesterone Caproate (Makena/compound) (PDF)
CP.PMN.193Hydroxyurea (Siklos, Xromi) (PDF)
CP.PHAR.378Ibalizumab-uiyk (Trogarzo) (PDF)
CP.PHAR.189Ibandronate Injection (Boniva) (PDF) Effective Date: 3/1/2025
CP.PHAR.126Ibrutinib (Imbruvica) (PDF) Effective Date: 5/1/2025
CP.PMN.120Ibuprofen/Famotidine (Duexis) (PDF)
CP.PHAR.178Icatibant (Firazyr) (PDF)
CP.PMN.187Icosapent Ethyl (Vascepa) (PDF) Effective Date: 3/1/2025
CP.PHAR.481Idecabtagene Vicleucel (Abecma) (PDF)
CP.PHAR.133Idelalisib (Zydelig) (PDF)
CP.PHAR.156Idursulfase (Elaprase) (PDF)
CP.PMN.32Iloperidone (Fanapt) (PDF)
CP.PHAR.193Iloprost (Ventavis) (PDF) Effective Date: 3/1/2025
CP.PHAR.65Imatinib (Gleevec, Imkeldi) (PDF)
CP.PHAR.690Imetelstat (Rytelo) (PDF)
CP.PHAR.154Imiglucerase (Cerezyme) (PDF)
CP.PHAR.103Immune Globulins (PDF)
CP.PHAR.702Inavolisib (Itovebi) (PDF) 
CP.PHAR.568Inclisiran (Leqvio) (PDF) Effective Date: 3/1/2025
CP.PHAR.231IncobotulinumtoxinA (Xeomin) (PDF)
CP.PHAR.458Inebilizumab-cdon (Uplizna) (PDF)
CP.PHAR.131Infertility and Fertility Preservation (PDF)
CP.PHAR.547Infigratinib (Truseltiq) (PDF)
HIM.PA.153Inhaled Agents for Asthma and COPD (PDF) Effective Date: 3/1/2025
CP.PHAR.405Inotersen (Tegsedi) (PDF)
CP.PHAR.359Inotuzumab Ozogamicin (Besponsa) (PDF)
CP.PHAR.534Insulin Delivery Systems (V-Go, Omnipod, InPen) Effective Date: 3/1/2025
HIM.PA.171Insulin Detemir (Levemir) (PDF)
HIM.PA.09Insulin Glargine (Rezvoglar, Semglee, Toujeo) (PDF)
CP.PHAR.52Interferon Gamma- 1b (Actimmune) (PDF)External Link Effective Date: 5/1/2025
CP.PHAR.255Interferon Beta-1a (Avonex, Rebif) (PDF)
CP.PCH.46Interferon Beta-1b (Betaseron, Extavia) (PDF)
CP.PHAR.459Iobenguane I-131 (Azedra) (PDF) Effective Date: 5/1/2025
CP.PHAR.319Ipilimumab (Yervoy) (PDF)
CP.PHAR.656Iptacopan (Fabhalta) (PDF)External Link
CP.PHAR.304Irinotecan Liposome (Onivyde) (PDF)
CP.PHAR.482Isatuximab-irfc (Sarclisa) (PDF)
CP.PMN.154Isavuconazonium (Cresemba) (PDF)
CP.PMN.143Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane) (PDF)
CP.PMN.217Istradefylline (Nourianz) (PDF) Effective Date: 3/1/2025
CP.PMN.124Itraconazole (Sporanox, Tolsura) (PDF)
CP.PMN.70Ivabradine (Corlanor) (PDF) Effective Date: 3/1/2025
CP.PHAR.210Ivacaftor (Kalydeco) (PDF) Effective Date: 3/1/2025
CP.PMN.269Ivermectin (Stromectol, Sklice) (PDF)
CP.PHAR.137Ivosidenib (Tibsovo) (PDF)
CP.PHAR.302Ixazomib (Ninlaro) (PDF)
CP.PMN.296Ketamine (Ketalar) (PDF)External Link
CP.PMN.282Ketorolac Nasal Spray (Sprix) (PDF)
HIM.PA.172Lanadelumab-fylo (Takhzyro) (PDF)
CP.PHAR.391Lanreotide (Somatuline Depot and Unbranded) (PDF)
CP.PHAR.391Lanreotide (Somatuline Depot) (PDF)
CP.PHAR.79Lapatinib (Tykerb) (PDF)
CP.PHAR.152Laronidase (Aldurazyme) (PDF)
CP.PHAR.414Larotrectinib (Vitrakvi) (PDF) Effective Date: 5/1/2025
CP.PMN.218Lasmiditan (Reyvow) (PDF) Effective Date: 5/1/2025
CP.PHAR.695Lazertinib (Lazcluze) (PDF)
CP.PHAR.704Lebrikizumab-lbkz (Ebglyss) (PDF)
CP.PHAR.596Lecanemab-irmb (Leqembi) (PDF)
HIM.PA.SP3Ledipasvir/Sofosbuvir (Harvoni) (PDF)
CP.PMN.219Lefamulin (Xenleta) (PDF)
CP.PHAR.622Lenacapavir (Sunlenca) (PDF)
CP.PHAR.71Lenalidomide (Revlimid) (PDF)
CP.PHAR.597Leniolisib (Joenja) (PDF)External Link
CP.PHAR.138Lenvatinib (Lenvima) (PDF)
CP.PHAR.367Letermovir (Prevymis) (PDF) Effective Date: 3/1/2025
CP.PHAR.173Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF)
CP.PCH.53Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)
CP.PHAR.682Levacetylleucine (Aqneursa) (PDF) Effective Date: 3/1/2025
CP.PMN.267Levodopa Inhalation Powder (Inbrija) (PDF)
CP.PMN.275Levoketoconazole (Recorlev) (PDF)
CP.PHAR.151Levoleucovorin (Fusilev, Khapzory) (PDF)
HIM.PA.125Levomilnacipran (Fetzima) (PDF)
CP.PMN.116L-glutamine (Endari) (PDF) (PDF)
CP.PMN.08Lidocaine Transdermal (Lidoderm, ZTlido) (PDF)
CP.PHAR.598Lifileucel (Amtagvi) (PDF)
CP.PMN.73Lifitegrast (Xiidra) (PDF) Effective Date: 5/1/2025
CP.PMN.27Linezolid (Zyvox) (PDF)
CP.PHAR.483Lisocabtagene Maraleucel (Breyanzi) (PDF)
CP.PMN.152Lofexidine (Lucemyra) (PDF)
CP.PHAR.507Lomustine (Gleostine) (PDF)
CP.PHAR.499Lonafarnib (Zokinvy) (PDF) Effective Date: 3/1/2025
CP.PHAR.539Loncastuximab Tesirine-lpyl (Zynlonta) (PDF)
CP.PMN.279Long-term Antibiotic Treatment for Tick-borne Diseases (PDF)
CP.PHAR.406Lorlatinib (Lorbrena) (PDF)
CP.PMN.260Loteprednol etabonate (Eysuvis) (PDF) Effective Date: 5/1/2025
CP.PMN.291Lotilaner (Xdemvy) (PDF)
CP.PHAR.627Lovotibeglogene Autotemcel (Lyfgenia) (PDF) Effective Date: 3/1/2025
CP.PMN.142Lubiprostone (Amitiza) (PDF)
CP.PMN.166Luliconazole Cream (Luzu) (PDF)External Link Effective Date: 3/1/2025
CP.PHAR.213Lumacaftor/Ivacaftor (Orkambi) (PDF) Effective Date: 3/1/2025
CP.PHAR.473Lumasiran (Oxlumo) (PDF) Effective Date: 5/1/2025
CP.PMN.232Lumateperone (Caplyta) (PDF)
CP.PHAR.500Lurbinectedin (Zepzelca) (PDF)
CP.PHAR.450Luspatercept-aamt (Reblozyl) (PDF)External Link Effective Date: 5/1/2025
CP.PHAR.407Lusutrombopag (Mulpleta) (PDF) Effective Date: 3/1/2025
CP.PHAR.384Lutetium Lu 177 Dotatate (Lutathera) (PDF)
CP.PHAR.582Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF)
CP.PHAR.194Macitentan (Opsumit) (PDF) Effective Date: 3/1/2025
CP.PHAR.518Mannitol (Bronchitol) (PDF)External Link
CP.PHAR.543Maralixibat (Livmarli) (PDF)
CP.PHAR.522Margetuximab-cmkb (Margenza) (PDF) Effective Date: 5/1/2025
CP.PMN.271Maribavir (Livtencity) (PDF) Effective Date: 3/1/2025
CP.PHAR.674Marstacimab-hncq (Hympavzi) (PDF) Effective Date: 3/1/2025
CP.PHAR.674Marstacimab-hncq (Hympavzi) (PDF) Effective Date: 3/1/2025
CP.PMN.272Mavacamten (Camzyos) (PDF)
CP.PHAR.679Mavorixafor (Xolremdi) (PDF)
CP.PMN.136Mecamylamine (Vecamyl) (PDF)
CP.PHAR.150Mecasermin (Increlex) (PDF)
CP.PHAR.381Mechlorethamine Gel (Valchlor) (PDF)
CP.PMN.179Megestrol Acetate (Megace ES) (PDF)
CP.PHAR.653Melphalan (Hepzato) (PDF)
CP.PHAR.535Melphalan flufenamide (Pepaxto) (PDF)
CP.PCH.30Memantine ER (Namenda XR), Memantine/Donepezil (Namzaric) (PDF)
HIM.PA.175
Mepolizumab (Nucala) (PDF) Effective Date: 5/1/2025
CP.PHAR.447Mercaptopurine (Purixan) (PDF)
CP.PMN.72Metformin ER (Fortamet, Glumetza) (PDF) Effective Date: 3/1/2025
CP.PHAR.134Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF)
HIM.PA.17Methoxsalen (Uvadex) (PDF)
CP.PHAR.238Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) (PDF)
CP.PMN.169Methylnaltrexone Bromide (Relistor) (PDF)External Link
CP.PMN.252Metoclopramide (Gimoti) (PDF)
CP.PHAR.425Metreleptin (Myalept) (PDF)
CP.PMN.211Midazolam (Nayzilam) (PDF)
CP.PHAR.344Midostaurin (Rydapt) (PDF)
CP.PHAR.101Mifepristone (Korlym) (PDF) Effective Date: 3/1/2025
CP.PHAR.394Migalastat (Galafold) (PDF)
CP.PHAR.164Miglustat (Zavesca) (PDF) Effective Date: 3/1/2025
CP.PHAR.164Miglustat (Zavesca) (PDF)
CP.PMN.125Milnacipran (Savella) (PDF)
CP.PMN.80Minocycline ER (Emrosi, Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF)
CP.PHAR.617Mirvetuximab Soravatansine-gynx (Elahere) (PDF) Effective Date: 5/1/2025
CP.PHAR.558Mitapivat (Pyrukynd) (PDF)
CP.PHAR.495Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF)
CP.PHAR.258Mitoxantrone (PDF)
CP.PHAR.559Mobocertinib (Exkivity) (PDF)
CP.PMN.39Modafinil (Provigil) (PDF)
CP.PHAR.139Mogamulizumab-kpkc (Poteligeo) (PDF)
CP.PHAR.654Momelotinib (Ojjaara) (PDF)
HIM.PA.93Mometasone (Nasonex) (PDF)
CP.PHAR.448Mometasone Furoate (Sinuva) (PDF)
CP.PHAR.618Mosunetuzumab-axgb (Lunsumio) (PDF) Effective Date: 3/1/2025
CP.PHAR.655Motixafortide (Aphexda) (PDF)
CP.PHAR.398Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF)
CP.PMN.287Nabumetone Double-Strength (Relafen DS) (PDF)
CP.PHAR.461Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF)External Link
CP.PHAR.174Nafarelin Acetate (Synarel) (PDF)
CP.PMN.112Naldemedine (Symproic) (PDF)
CP.PHAR.638Nalmefene (Opvee) (PDF)
HIM.PA.167Naloxegol (Movantik) (PDF)
CP.PHAR.96Naltrexone (Vivitrol) (PDF) Effective Date: 5/1/2025
HIM.PA.130Naproxen Oral Suspension (Naprosyn) (PDF)
CP.PMN.117Naproxen/Esomeprazole (Vimovo) (PDF)
CP.PHAR.259Natalizumab (Tysabri, Tyruko) (PDF)
CP.PHAR.523Naxitamab-gqgk (Danyelza) (PDF) Effective Date: 3/1/2025
CP.PHAR.320Necitumumab (Portrazza) (PDF)Nedosiran (Rivfloza)
CP.PHAR.619Nedosiran (Rivfloza) (PDF) Effective Date: 5/1/2025
CP.PHAR.703 Nemolizumab-ito (Nemluvio) (PDF) Effective Date: 3/1/2025
CP.PMN.167Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF)
CP.PHAR.365 Neratinib (Nerlynx) (PDF)
CP.PMN.158Netupitant and Palonosetron (Akynzeo), Fosnetupitant and Palonosetron (Akynzeo IV) (PDF)
CP.PMN.256Nifurtimox (Lampit) (PDF)
CP.PHAR.76Nilotinib (Tasigna, Danziten) (PDF)
CP.PCH.54Nintedanib (Ofev) (PDF) Effective Date: 3/1/2025
CP.PHAR.645Niraparib + Abiraterone (Akeega) (PDF)
CP.PHAR.408Niraparib (Zejula) (PDF) Effective Date: 5/1/2025
CP.PMN.288Nirmatrelvir and Ritonavir (Paxlovid) (PDF)External Link
CP.PHAR.671Nirogacestat (Ogsiveo) (PDF) Effective Date: 5/1/2025
CP.PHAR.121Nivolumab (Opdivo) (PDF) Effective Date: 5/1/2025
CP.PHAR.614Nirsevimab-alip (Beyfortus) (PDF)
HIM.PA.152Nitazoxanide (Alinia) (PDF)
CP.PHAR.132Nitisinone (Nityr, Orfadin) (PDF)
CP.PHAR.588Nivolumab and Relatlimab-rmbw (Opdualag) (PDF)
HIM.PA.33No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF)
CP.PHAR.684Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF)
CP.PMN.04Non-Calcium Phosphate Binders (PDF) Effective Date: 3/1/2025
HIM.PA.100Non-Formulary and Formulary Contraceptives (PDF)
HIM.PA.34Non-Formulary Test Strips (PDF) Effective Date: 3/1/2025
CP.PHAR.327Nusinersen (Spinraza) (PDF) Effective Date: 3/1/2025
CP.PHAR.675Obecabtagene autoleucel (Aucatzyl) (PDF) Effective Date: 3/1/2025
CP.PHAR.287Obeticholic Acid (Ocaliva) (PDF)
CP.PHAR.305Obinutuzumab (Gazyva) (PDF)Ocrelizumab (Ocrevus)
CP.PHAR.335Ocrelizumab (Ocrevus) (PDF)
CP.PHAR.40Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Mycapssa) (PDF) Effective Date: 5/1/2025
CP.PHAR.528Odevixibat (Bylvay) (PDF)
CP.PHAR.306Ofatumumab (Arzerra, Kesimpta) (PDF)
HIM.PA.154Off-Label Drug Use (PDF)
CP.PHAR.292Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF)
CP.PMN.265Olanzapine/Samidorphan (Lybalvi) (PDF)
CP.PHAR.360Olaparib (Lynparza) (PDF) Effective Date: 5/1/2025
CP.PHAR.615Olutasidenib (Rezlidhia) (PDF) Effective Date: 3/1/2025
CP.PHAR.108Omacetaxine (Synribo) (PDF)
CP.PMN.188Omadacycline (Nuzyra) (PDF)
CP.PCH.49Omalizumab (Xolair) (PDF) Effective Date: 5/1/2025
CP.PHAR.590Omaveloxolone (Skyclarys) (PDF)
CP.PHAR.232OnabotulinumtoxinA (Botox) (PDF)
CP.PHAR.421Onasemnogene Abeparvovec (Zolgensma) (PDF)
CP.PMN.45Ondansetron (Zuplenz) (PDF)
HIM.PA.03Ophthalmic Corticosteroids (PDF)
CP.PHAR.536Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF)
CP.PMN.245Opicapone (Ongentys) (PDF)
HIM.PA.139Opioid Analgesics (PDF)
CP.PHAR.487Osilodrostat (Isturisa) (PDF)
CP.PHAR.294Osimertinib (Tagrisso) (PDF)
CP.PMN.168Ospemifene (Osphena) (PDF)
CP.PMN.198Overactive Bladder Agents (PDF)
CP.PMN.86Oxymetazoline (Rhofade, Upneeq) (PDF)
CP.PHAR.462Ozanimod (Zeposia) (PDF)
CP.PMN.119Ozenoxacin (Xepi) (PDF)
CP.PHAR.176Paclitaxel, Protein-Bound (Abraxane) (PDF)
CP.PHAR.583Pacritinib (Vonjo) (PDF)
HIM.PA.173Palbociclib (Ibrance) (PDF)
CP.PHAR.291Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF)
CP.PHAR.16Palivizumab (Synagis) (PDF)
CP.PHAR.696Palopegteriparatide (Yorvipath) (PDF)
CP.PHAR.548Palovarotene (Sohonos) (PDF)
CP.PCH.44Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF)
CP.PHAR.321Panitumumab (Vectibix) (PDF)
CP.PHAR.395Patisiran (Onpattro) (PDF)
CP.PHAR.382Panobinostat (Farydak) (PDF)
CP.PHAR.282Parathyroid Hormone (Natpara) (PDF) Effective Date: 3/1/2025
CP.PHAR.270Paricalcitol Injection (Zemplar) (PDF)
CP.PHAR.332Pasireotide (Signifor, Signifor LAR)  (PDF)
CP.PMN.205Patiromer (Veltassa) (PDF)
CP.PHAR.81Pazopanib (Votrient) (PDF)
CP.PMN.220Peanut Allergen Powder-dnfp (Palforzia) (PDF)
CP.PHAR.353Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF)
CP.PHAR.524Pegcetacoplan (Empaveli, Syfovre) (PDF)
CP.PHAR.296Pegfilgrastim (Neulasta and biosimilars) (PDF)
CP.PHAR.89Peginterferon Alfa-2a (Pegasys) (PDF)
CP.PHAR.271Peginterferon Beta-1a (Plegridy) (PDF)
CP.PHAR.115Pegloticase (Krystexxa) (PDF) Effective Date: 3/1/2025
CP.PHAR.512Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF)
CP.PHAR.140Pegvaliase-pqpz (Palynziq) (PDF)
CP.PHAR.389Pegvisomant (Somavert)  (PDF)
CP.PHAR.322Pembrolizumab (Keytruda) (PDF)
CP.PHAR.368Pemetrexed (Alimta, Pemfexy) (PDF) Effective Date: 5/1/2025
CP.PHAR.496Pemigatinib (Pemazyre) (PDF)
CP.PCH.09Penicillamine (Cuprimine) (PDF)
CP.PMN.156Perampanel (Fycompa) (PDF)
CP.PMN.290Perfluorohexyloctane (Miebo) (PDF)
CP.PHAR.227Pertuzumab (Perjeta) (PDF)
CP.PHAR.501Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF)
CP.PHAR.436Pexidartinib (Turalio) (PDF)
CP.PCH.47Phendimetrazine (PDF)
CP.PCH.13Phentermine (Adipex-P, Lomaira) (PDF)
CP.PMN.270Pilocarpine (Qlosi, Vuity) (PDF)
CP.PMN.140Pimavanserin (Nuplazid) (PDF)
CP.PHAR.286Pirfenidone (Esbriet) (PDF) Effective Date: 3/1/2025
CP.PHAR.620Pirtobrutinib (Jaypirca) (PDF)
CP.PMN.221Pitolisant (Wakix) (PDF)
CP.PHAR.513Plasminogen, Human-tvmh (Ryplazim) (PDF)
CP.PMN.87Plecanatide (Trulance) (PDF)
CP.PHAR.323Plerixafor (Mozobil) (PDF)
CP.PHAR.433Polatuzumab Vedotin-piiq (Polivy) (PDF)
CP.PHAR.116Pomalidomide (Pomalyst) (PDF)
CP.PHAR.112Ponatinib (Iclusig) (PDF)
CP.PHAR.537Ponesimod (Ponvory) (PDF)
HIM.PA.143Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF) Effective Date: 3/1/2025
CP.PHAR.626Pozelimab-bbfg (Veopoz) (PDF)
CP.PHAR.313Pralatrexate (Folotyn) (PDF) (PDF)
CP.PMN.129Pramlintide (Symlin) (PDF) Effective Date: 3/1/2025
CP.PMN.99Prasterone (Intrarosa) (PDF) Effective Date: 3/1/2025
CP.PMN.33Pregabalin (Lyrica, Lyrica CR) (PDF)
CP.PMN.222Pretomanid (PDF) Effective Date: 3/1/2025
CP.PMN.243Progesterone (Crinone, Endometrin, Milprosa) (PDF)
CP.PCH.51Propranolol HCl Oral Solution (Hemangeol) (PDF)
CP.PHAR.330Protein C Concentrate, Human (Ceprotin) (PDF) Effective Date: 3/1/2025
HIM.PA.159Prucalopride (Motegrity) (PDF) Effective Date: 5/1/2025
CP.PMN.44Pyrimethamine (Daraprim) (PDF)
CP.PMN.59Quantity Limit Override and Dose Optimization (PDF)
CP.PMN.64Quetiapine Extended-Release (Seroquel XR) (PDF) Effective Date: 5/1/2025
CP.PMN.262Quinine Sulfate (Qualaquin) (PDF)
CP.PHAR.646Quizartinib (Vanflyta) (PDF)
CP.PHAR.119Ramucirumab (Cyramza) (PDF) Effective Date: 5/1/2025
CP.PHAR.186Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF) Effective Date: 5/1/2025
HIM.PA.89Rasagiline (Azilect) (PDF)
CP.PHAR.415Ravulizumab-cwvz (Ultomiris) (PDF)
CP.PHAR.107Regorafenib (Stivarga) (PDF)
CP.PHAR.529Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF)
HIM.PA.168Repository Corticotropin Injection (Acthar Gel, Purified Cortrophin Gel) (PDF)
CP.PHAR.667Repotrectinib (Augtyro) (PDF) Effective Date: 5/1/2025
CP.PHAR.223Reslizumab (Cinqair) (PDF) Effective Date: 5/1/2025
CP.PHAR.647Resmetirom (Rezdiffra) (PDF)
CP.PHAR.658Respiratory syncytial virus vaccine (Abrysvo) (PDF)External Link
CP.PHAR.629Retifanlimab-dlwr (Zynyz) (PDF)
CP.PHAR.707Revumenib (Revuforj) (PDF) Effective Date: 3/1/2025
CP.PHAR.141Ribavirin (Rebetol, Ribasphere RibaPak) (PDF)
CP.PHAR.334Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara) (PDF)
CP.PMN.223Rifabutin (Mycobutin) (PDF) Effective Date: 3/1/2025
CP.PMN.196Rifamycin (Aemcolo) (PDF)
CP.PMN.47Rifaximin (Xifaxan) (PDF)
CP.PHAR.266Rilonacept (Arcalyst) (PDF)
CP.PHAR.233RimabotulinumtoxinB (Myobloc) (PDF)
CP.PHAR.490Rimegepant (Nurtec ODT) (PDF)
CP.PHAR.195Riociguat (Adempas) (PDF) Effective Date: 3/1/2025
CP.PHAR.477Risdiplam (Evrysdi) (PDF) Effective Date: 3/1/2025
CP.PMN.100Risedronate (Actonel, Atelvia) (PDF) Effective Date: 5/1/2025
CP.PHAR.293Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (PDF)
CP.PHAR.260Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF)
CP.PMN.46Roflumilast (Daliresp, Zoryve) (PDF)
CP.PMN.102Rolapitant (Varubi) (PDF)
CP.PHAR.314Romidepsin (Istodax) (PDF)
CP.PHAR.179Romiplostim (Nplate) (PDF) Effective Date: 
CP.PHAR.428Romosozumab-aqqg (Evenity) (PDF) Effective Date: 3/1/2025
CP.PHAR.570Ropeginterferon Alfa-2b-njft (BESREMi) (PDF) Effective Date: 5/1/2025
CP.PHAR.648Rozanolixizumab-noli (Rystiggo) (PDF)
CP.PHAR.35Rucaparib (Rubraca) (PDF) Effective Date: 5/1/2025
CP.PMN.157Rufinamide (Banzel) (PDF)
CP.PHAR.98Ruxolitinib (Jakafi, Opzelura) (PDF) Effective Date: 3/1/2025
CP.PHAR.475Sacituzumab Govitecan-hziy (Trodelvy) (PDF)
CP.PCH.52Sacubitril/Valsartan (Entresto) (PDF) Effective Date: 3/1/2025
CP.PMN.113Safinamide (Xadago) (PDF) Effective Date: 3/1/2025
CP.PHAR.43Sapropterin Dihydrochloride (Kuvan) (PDF0
CP.PMN.189Sarecycline (Seysara) (PDF) Effective Date: 3/1/2025
CP.PHAR.295Sargramostim (Leukine) (PDF)
CP.PHAR.463Satralizumab-mwge (Enspryng) (PDF)
CP.PHAR.159Sebelipase Alfa (Kanuma) (PDF)
CP.PMN.103Secnidazole (Solosec) (PDF) Effective Date: 3/1/2025
CP.PHAR.698Seladelpar (Livdelzi) (PDF)
CP.PHAR.196Selexipag (Uptravi) (PDF) Effective Date: 3/1/2025
CP.PHAR.431Selinexor (Xpovio) (PDF)
CP.PHAR.464Selumetinib (Koselugo) (PDF) Effective Date: 5/1/2025
CP.PMN.295Semaglutide (Wegovy) (PDF)
CP.PHAR.491Setmelanotide (Imcivree) (PDF) Effective Date: 3/1/2025
HIM.PA.91 SGLT2SGLT2 inhibitors (PDF) Effective Date: 3/1/2025
CP.PMN.83Short Ragweed Pollen Allergen Extract (Ragwitek) (PDF)
CP.PCH.07Sildenafil for ED (Viagra) (PDF)
CP.PHAR.197Sildenafil (Revatio, Liqrev) (PDF) Effective Date: 3/1/2025
CP.PHAR.329Siltuximab (Sylvant) (PDF) Effective Date: 3/1/2025
CP.PHAR.427Siponimod (Mayzent) (PDF)
CP.PHAR.120Sipuleucel-T (Provenge) (PDF)
CP.PHAR.574Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF) Effective Date: 5/1/2025
CP.PMN.42Sodium Oxybate (Xyrem, Lumryz) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) (PDF)
CP.PHAR.208Sodium Phenylbutyrate (Buphenyl, Pheburane, Olpruva) (PDF) Effective Date: 3/1/2025
CP.PHAR.584Sodium Phenylbutyrate/Taurursodiol (Relyvrio) (PDF)
CP.PMN.163Sodium Zirconium Cyclosilicate (Lokelma) (PDF)
HIM.PA.91Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors (PDF)
CP.PHAR.610Sodium Thiosulfate (Pedmark) (PDF) Effective Date: 5/1/2025
HIM.PA.SP2Sofosbuvir (Sovaldi) (PDF)
HIM.PA.SP1Sofosbuvir/Velpatasvir (Epclusa) (PDF)
HIM.PA.SP63Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (PDF)
CP.PMN.209Solriamfetol (Sunosi) (PDF)
CP.PHAR.272Sonidegib (Odomzo) (PDF)
CP.PHAR.69Sorafenib (Nexavar) (PDF)
CP.PHAR.657Sotatercept (Winrevair) (PDF) Effective Date: 5/1/2025
CP.PHAR.549Sotorasib (Lumakras) (PDF)
CP.PHAR.631Sparsentan (Filspari) (PDF)
CP.PHAR.606Spesolimab-sbzo (Spevigo) (PDF)
HIM.PA.134Spinosad (Natroba) (PDF)
HIM.PA.109Step Therapy (PDF)
CP.PMN.184Stiripentol (Diacomit) (PDF)
CP.PHAR.73Sunitinib (Sutent) (PDF)
CP.PHAR.503Sutimlimab-jome (Enjaymo) (PDF)
CP.PMN.109Suvorexant (Belsomra) (PDF)
CP.PMN.85Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract (Oralair) (PDF)
CP.PHAR.198Tadalafil (Adcirca, Alyq, Tadliq) (PDF) Effective Date: 3/1/2025
CP.PMN.132Tadalafil BPH - ED (Cialis) (PDF)
CP.PHAR.432Tafamidis (Vyndaqel, Vyndamax) (PDF)
CP.PHAR.508Tafasitamab-cxix (Monjuvi) (PDF)
CP.PHAR.409Talazoparib (Talzenna) (PDF) Effective Date: 5/1/2025
CP.PHAR.157Taliglucerase Alfa (Elelyso) (PDF)
CP.PHAR.542Talimogene laherepvec (Imlygic) (PDF)
CP.PHAR.649Talquetamab-tgvs (Talvey) (PDF)
CP.PMN.283Tapinarof (Vtama) (PDF)External Link
CP.PHAR.685Tarlatamab-dlle (Imdelltra) (PDF)
CP.PMN.104Tasimelteon (Hetlioz, Hetlioz LQ) (PDF) Effective Date: 3/1/2025
CP.PMN.105Tavaborole (Kerydin) (PDF) Effective Date: 3/1/2025 
CP.PMN.244Tazarotene (Arazlo, Fabior, Tazorac) (PDF)
CP.PHAR.452Tazemetostat (Tazverik) (PDF) Effective Date: 5/1/2025
CP.PHAR.575Tebentafusp-tebn (Kimmtrak) (PDF)
CP.PHAR.611Teclistamab-cqyv (Tecvayli) (PDF) Effective Date: 5/1/2025
CP.PMN.62Tedizolid (Sivextro) (PDF)
CP.PHAR.114Teduglutide (Gattex) (PDF) Effective Date: 3/1/2025
CP.PHAR.337Telotristat Ethyl (Xermelo) (PDF)
CP.PHAR.77Temozolomide (Temodar) (PDF)
CP.PHAR.324Temsirolimus (Torisel) (PDF)
HIM.PA.174Tenapanor (Ibsrela, Xphozah) (PDF) Effective Date: 3/1/2025
CP.PMN.268Tenofovir Alafenamide Fumarate (Vemlidy) (PDF)
CP.PHAR.492Teplizumab-mzwv (Tzield) (PDF) Effective Date: 5/1/2025
CP.PHAR.530Tepotinib (Tepmetko) (PDF)
CP.PHAR.465Teprotumumab (Tepezza) (PDF) Effective Date: 3/1/2025
CP.PHAR.188Teriparatide (Forteo, Bonsity) (PDF) Effective Date: 3/1/2025
CP.PCH.40Teriflunomide (Aubagio) (PDF)
CP.PHAR.109Tesamorelin (Egrifta SV) (PDF)
HIM.PA.87Testosterone (Androderm) (PDF)
CP.PHAR.354Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF)
CP.PHAR.92Tetrabenazine (Xenazine) (PDF)
CP.PHAR.377Tezacaftor/Ivacaftor; Ivacaftor (Symdeko) (PDF)
HIM.PA.176Tezepelumab (Tezspire) (PDF) Effective Date: 5/1/2025
CP.PHAR.78Thalidomide (Thalomid) (PDF)
CP.PHAR.437Thioguanine (Tabloid) (PDF)
CP.PHAR.95Thyrotropin Alfa (Thyrogen) (PDF)External Link
CP.PMN.84Timothy Grass Pollen Allergen Extract (Grastek) (PDF)
CP.PCH.50Tiopronin Delayed-Release (Thiola EC) (PDF)
CP.PHAR.361Tisagenlecleucel (Kymriah) (PDF) Effective Date: 3/1/2025
CP.PHAR.686Tislelizumab-jsgr (Tevimbra) (PDF)
CP.PMN.298Tirzepatide (Zepbound) (PDF) Effective Date: 3/1/2025
CP.PHAR.561Tisotumab Vedotin-tftv (Tivdak) (PDF)
CP.PHAR.538Tivozanib (Fotivda) (PDF) 
CP.PHAR.211Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) (PDF)
CP.PHAR.591Tofersen (Qalsody) (PDF)
CP.PHAR.27Tolvaptan (Jynarque, Samsca) (PDF)
HIM.PA.71Topical Acne Treatment (PDF)
CP.PMN.107Topical Immunomodulators (PDF) Effective Date: 3/1/2025
CP.PMN.281Topiramate Extended-Release (Qudexy XR, Trokendi XR) (PDF)External Link
CP.PHAR.64Topotecan (Hycamtin) (PDF)
CP.PHAR.668Toripalimab-tpzi (Loqtorzi) (PDF) Effective Date: 3/1/2025
CP.PHAR.687Tovorafenib (Ojemda) (PDF)
CP.PHAR.204Trabectedin (Yondelis) (PDF) Effective Date: 5/1/2025
CP.PHAR.577Tralokinumab-ldrm (Adbry) (PDF)
CP.PHAR.240Trametinib (Mekinist) (PDF)
CP.PHAR.228Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF)
CP.PHAR.672Travoprost Implant (iDose TR) (PDF) Effective Date: 3/1/2025
CP.PHAR.612Tremelimumab-actl (Imjudo) (PDF) Effective Date: 5/1/2025
CP.PHAR.199Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI) (PDF) Effective Date: 3/1/2025
CP.PHAR.371Triamcinolone ER Injection (Zilretta) (PDF) Effective Date: 5/1/2025
CP.PMN.207Triclabendazole (Egaten) (PDF)
CP.PHAR.438Trientine (Cuvrior, Syprine) (PDF)External Link
CP.PMN.225Trifarotene (Aklief) (PDF) Effective Date: 3/1/2025
CP.PHAR.383Trifluridine/Tipiracil (Lonsurf) (PDF)
CP.PHAR.509Triheptanoin (Dojolvi) (PDF)
CP.PHAR.175Triptorelin Pamoate (Trelstar, Triptodur) (PDF)
CP.PHAR.600Trofineatide (Daybue) (PDF)
CP.PHAR.497Tucatinib (Tukysa) (PDF)External Link
CP.PHAR.621Ublituximab-xiiy (Briumvi) (PDF)
CP.PMN.277Ulcer Therapy Products (Omeclamox Pak, Pylera, Talicia, Voquezna) (PDF)
CP.PHAR.531Umbralisib (Ukoniq) (PDF)
HIM.PA.SP55Uridine Triacetate (Vistogard) (PDF)
CP.PHAR.677Vadadustat (Vafseo) (PDF)
CP.PCH.48Valbenazine (Ingrezza, Ingrezza Sprinkle) (PDF)
CP.PCH.06Valganciclovir (Valcyte) (PDF) Effective Date: 3/1/2025
CP.PHAR.466Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF) Effective Date: 3/1/2025
CP.PHAR.439Valrubicin (Valstar) (PDF)
CP.PHAR.659Vamorolone (Agamree) (PDF) Effective Date: 3/1/2025
CP.PHAR.80Vandetanib (Caprelsa) (PDF) Effective Date: 3/1/2025
CP.PMN.273Varenicline (Tyrvaya) (PDF) Effective Date: 5/1/2025
CP.PHAR.163Velaglucerase Alfa (VPRIV) (PDF)
CP.PHAR.601Velmanase Alfa-tycv (Lamzede) (PDF)
CP.PHAR.91Vemurafenib (Zelboraf) (PDF) Effective Date: 
CP.PHAR.129Venetoclax (Venclexta) (PDF)
CP.PHAR.187Verteporfin (Visudyne) (PDF) Effective Date: 5/1/2025
CP.PHAR.374Vestronidase Alfa-vjbk (Mepsevii) (PDF)
CP.PHAR.169Vigabatrin (Sabril) (PDF)
CP.PMN.264Viloxazine (Qelbree) (PDF)
CP.PHAR.484Viltolarsen (Viltepso) (PDF) Effective Date: 3/1/2025
CP.PHAR.273Vismodegib (Erivedge) (PDF)
CP.PHAR.504Voclosporin (Lupkynis) (PDF)
HIM.PA.146Vorapaxar (Zontivity) (PDF) Effective Date: 3/1/2025
CP.PHAR.699Vorasidenib (Voranigo) (PDF)
CP.PHAR.372Voretigene Neparvovec-rzyl (Luxturna) (PDF)External Link Effective Date: 3/1/2025
CP.PHAR.83Vorinostat (Zolinza) (PDF)
CP.PMN.65Vortioxetine (Trintellix) (PDF)
CP.PHAR.525Vosoritide (Voxzogo) (PDF) Effective Date: 3/1/2025
CP.PHAR.451Voxelotor (Oxbryta) (PDF) Effective Date: 3/1/2025
CP.PHAR.550Vutrisiran (Amvuttra) (PDF)
CP.PMN.299Xanomeline-trospium chloride (Cobenfy) (PDF) Effective Date: 3/1/2025
CP.PHAR.709Zanidatamab-hrii (Ziihera) (PDF) Effective Date: 3/1/2025
CP.PHAR.467Zanubrutinib (Brukinsa) (PDF) Effective Date: 5/1/2025
CP.PHAR.630Zavegepant (Zavzpret) (PDF)
CP.PHAR.713Zenocutuzumab-zbco (Bizengri) (PDF) Effective Date: 3/1/2025
CP.PHAR.616Zilucoplan (Zilbrysq) (PDF) Effective Date: 3/1/2025
CP.PHAR.325Ziv-aflibercept (Zaltrap) (PDF)
CP.PHAR.705Zolbetuximab-clzb (Vyloy) (PDF)
CP.PHAR.59Zoledronic Acid (Reclast) (PDF) Effective Date: 5/1/2025
CP.PHAR.650Zuranolone (Zurzuvae) (PDF)